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Abstract

Background: Hyperhidrosis is a disorder characterized by excessive sweating, predominantly of
the hands, axillae, and feet. Patients suffering from severe hyperhidrosis who have not responded
well to non-invasive treatments such as botulinum toxin injections or prescription antiperspirants
may undergo an endoscopic thoracic sympathectomy (ETS). An ETS involves cauterizing or, more
recently, clipping the sympathetic nerves at the T2-T3 vertebral level just lateral to the sympathetic
trunk. The procedure generally decreases the amount of sweating in the original problematic area;
however, a major side effect is compensatory sweating and increased total body sweating. Patient
satisfaction with this procedure has been reported at rates ranging from 29-95%. This paper illustrates
a single case of primary hyperhidrosis and discusses the results of ETS therapy at a single institution.

Introduction

Primary hyperhidrosis is a condition characterized typically by palmar and/or axillary sweating in
excess of the body’s physiologic demand. The prevalence of hyperhidrosis in the United States is
estimated to be 2.8%. For patients who suffer from excessive, in some cases constant perspiration,
the implications can be embarrassing (cold wet handshakes) or even debilitating (soiled paperwork).
One national survey of individuals with hyperhidrosis reported that 21.6% found their sweating
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Figure 1
Effects of ETS surgery by location. Chart shows percentages of patients in study reporting
excessive perspiration in specific regions of body prior to, and following, ETS surgery
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barely tolerable and frequently interfering with
their daily activities, while another 10.8% found
it intolerable and always interfering. In the
same study, 13.4% of sufferers reported having
lost time at work as a direct result of sweating
attacks.13
While the etiology of hyperhidrosis is unclear, it
is classically believed to result from dysfunction
of the sympathetic nervous system, leading to
excessive stimulation of eccrine sweat glands.
This over-activation may originate in the
hypothalamus, or peripherally at the synapses
between the sympathetic neurons and the sweat
glands themselves.2,11 The vagueness of primary
hyperhidrosis’ pathophysiology has hampered
its treatment over the last one and half centuries
of documented medical therapies.
There are several non-invasive therapeutic
options for hyperhidrosis, including botulinum
toxin injections and prescription antiperspirants. For patients who do not respond well to
these treatments, surgical options are often considered. Since the 1920’s, endoscopic thoracic
sympathectomy (ETS) has been a mainstay of
hyperhidrosis therapy for medically refractory
patients.12 This procedure involves deflation of
the lung and endoscopic clipping or disruption
of the segmental sympathetic roots at T2-3
(figures 2a & 2b). ETS generally decreases the
amount of sweating in the original problematic
area, however a cache of potential side-effects
have made it a somewhat controversial therapy.
Post-operative complications such as pneumothoraces, bradycardia, dysesthesias, iatrogenic
Horner’s syndrome, palmar over-dryness, and
rebound sweating have all been commonly
reported in the literature.3 Due to the largely
social/psychological quality of both the benefits
of successful ETS and risks of its most severe
potential side effects, the overall value of this
surgery to the patient is essentially subjective.
This paper describes a single case of primary
hyperhidrosis treated with ETS and reviews
the outcomes of ETS therapy noted at a single
institution over the last 10 years.

Patient Case

JH is a 17 year old female who presented with
severe, bilateral palmar and plantar sweating.
Her symptoms were increased with stressful
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Figure 2
Sympathetic trunk. An ETS involves cauterizing or clipping the sympathetic nerves at the T2-T3 vertebral level just lateral to the sympathetic trunk.
Images courtesy and copyright of Primal Pictures Ltd
social situations and were disproportionate
to the situations themselves. Compared to
her plantar skin, her palmer sweating was
consistently more severe. These episodes
of hyperhidrosis did not accompany any
discomfort or skin discoloration. A physical
exam and review of symptoms did not elicit any
other pertinent findings.
JH was initially treated with a course of antiperspirant medications, including aluminum
chloride hexahydrate, iontophoresis, and oral
beta blockers which failed to provide sufficient
symptom relief. An endoscopic thoracic sympathectomy (ETS) was therefore chosen as the
next step in treatment.
The patient was taken to the operating room
and positioned in the lateral decubitus with
the posterior-, mid-, and anterior-axillary lines
exposed and easily accessible. Two endoscopic
ports were placed after a sterile prep. One port
entered in the 3rd intercostal space between the
anterior- and mid-axillary lines; a second port
entered in the 5th intercostal space between the
anterior- and mid-axillary lines. The ipsilateral
lung was deflated and gently retracted medially
to expose the costovertebral junction. Once the
sympathetic chain was identified, a harmonic
scalpel was used for endoscopic dissection to

unveil the T2 and T3 ganglia. The surgeon then
clipped these ganglia. Following hemostasis, the
lung was reinflated, and the ports were removed
and closed. This procedure was repeated on
the contralateral side. At the end of the case,
bilateral chest tubes were left.
After the ETS, JH reported a significant
reduction in plantar and, more significantly,
palmer perspiration. No evidence of increased
perspiration in other areas of their body could
be found, and the patient did not suffer any
complications. On postoperative day #2, the
chest X-rays showed no pneumothoraces, and
the chest tubes were removed. The patient was
discharged in good health on postoperative
day #2.

Discussion

The symptoms of hyperhidrosis can have
dramatic social and psychological implications
in the day-to-day lives of patients. In many
cases, the perspiratory pathology can be sufficiently controlled through conservative treatments such as aluminum chloride, botulinum
injections, and ditropan.5 Certain patients,
for whom these non-invasive measures are
inadequate, may achieve greater relief of their
hyperhidrosis symptoms through surgical ligation of the thoracic sympathetic chain. Palmar

hyperhidrosis has been found to be the most
responsive subset of symptoms to surgical
intervention.4, 6,14 In a review of 83 patients
treated with ETS at our institution between
1997 and 2007, we witnessed similarly positive
results when treating palmar hyperhidrosis
(figure 1). Our data demonstrated a 9-fold
reduction in palmar hyperhidrosis complaints
post ETS surgery when compared to prior (88%
to 10%, p < 0.001).
Past authors have suggested that thoracic
sympathectomies may have a positive effect on
plantar hyperhidrosis as well, however a wide
range of cure rates (3-64%) have been reported.4,
7,10,15
Our own experience yielded similar results.
We found a small and statistically insignificant
decrease in plantar hyperhidrosis complaints
following ETS. This trend towards reduced
plantar perspiration was recognized in 17% of
patients, including the case presented above.
Possibly, with a larger cohort, the finding may
reach significance. Compounding this vagueness is the fact that the mechanism through
which ETS relieves plantar hyperhidrosis
remains unclear. The relevant sympathetic
pathways bypass the thoracic chain, leaving the
spinal medulla between T10 and L2, well caudal
to location of ETS ligation.9 Plantar hyperhi-

JHN JOURNAL

17

drosis’ response to ETS surgery is unpredictable, and in some series, initially positive results
have been noted to fade over time.15 Taking all
this into account, it is not recommended that
plantar hyperhidrosis alone be used to justify an
ETS procedure.
Palmar hyperhidrosis is recognized as the
most socially detrimental symptom of primary
hyperhidrosis. The palms are used extensively
in daily activities and personal interactions, and
excessive perspiration may be embarrassing and
difficult to disguise. This may account for the
fact that in many studies the palmar symptom
response to ETS surgery seems to dictate overall
patient satisfaction. 6
In our review of 83 ETS patients, we noted a
substantial reduction in palmar hyperhidrosis,
with overall patient satisfaction of 95%. We
found this to be in line with past reports.4,6,14 This
high level of patient satisfaction is particularly
interesting given the rates of post-surgical side
effects; 66% of patients reported compensatory
sweating and 44% reported gustatory sweating.
Our data found no indication that gustatory
sweating had any impact on overall patient
satisfaction. As for compensatory sweating,
though several authors have argued that it also
has no effect on overall satisfaction, our data
suggest that it does have a moderate impact. 6
Patients experiencing compensatory hyperhidrosis still rated their ETS experience positively,
though to a lesser degree than those free of the
side effect (6.0/10 versus 8.9/10, respectively).
This rather intuitive trend was explored further
in a study by Chwajol, et al., which found that
“severe” compensatory hyperhidrosis negatively impacted patient satisfaction rates with
ETS. They suggested that T3 ganglionectomies,
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as part of ETS surgery, may help reduce compensatory hyperhidrosis, thereby improving
subjective patient outcomes.1,8
Pain, both local to the surgical site and distant,
is increasingly being recognized as a potential
side effect of ETS. Despite this, few long-term
studies of ETS outcomes have focused on its
prevalence. We specifically questioned patients
about post-surgical pain. No complaints of
significant surgical site, axillary, facial, or arm
pain were reported.14

Conclusion
ETS surgery is a tested and effective intervention
for hyperhidrosis. In a well selected patient
population, we found a success rate of 95%. The
procedure has a significant impact on palmar
and axillary hyperhidrosis. Its ability to reduce
plantar hyperhidrosis, via pathways yet to be
understood, was suggested by this study, though
a more robust cohort may be neceessary to
demonstrate a significant effect. Compensatory
hyperhidrosis and gustatory sweating are not
uncommon after this procedure. Patients
should be counseled in the preoperative period
about these side effects, though their overall
effect on post-procedure patient quality of life
appears minimal.
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